newsfilter
← Latest News
Business Wire·

Infinity Pharmaceuticals Announces Stockholder Approval of Merger with MEI Pharma

Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) ("Infinity"), a clinical-stage biotechnology company developing eganelisib, a first-in-class, oral, immuno-oncology macrophage reprogramming drug candidate, announced that,